Who is sponsoring NCT04083586?

NCT04083586 is sponsored by Assiut University.

What drugs are being tested in NCT04083586?

Interventions in NCT04083586: All investigations; laboratory and radiological, needed for diagnosis.

What condition does NCT04083586 study?

NCT04083586 studies Involuntary Movements.

Is NCT04083586 still recruiting?

NCT04083586 is currently completed. Last updated 9 August 2021.

Last reviewed 2021-08-09 · How we verify

NCT04083586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pattern and Frequency of Non-epileptic Involuntary Movements

Completed Last updated 9 August 2021

What this trial tests

trial testing All investigations; laboratory and radiological, needed for diagnosis in Involuntary Movements in 144 participants. Completed in 15 January 2021.

Timeline

15 January 2020

Primary endpoint
15 January 2021

15 January 2021

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	144
Start date	15 January 2020
Primary completion	15 January 2021
Estimated completion	15 January 2021
Sites	1 location across Egypt

Drugs / interventions tested

All investigations; laboratory and radiological, needed for diagnosis

Conditions studied

Involuntary Movements — all drugs for Involuntary Movements →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Involuntary Movements. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will perform a medical record review of all patients seen in Assiut University hospital, Egypt, to determine the frequency of movement disorders seen, disease characteristics, diagnostic evaluations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04083586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 9 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04083586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing